Indena cosmetic ingredients will be distributed in Germany, Austria and Benelux by C.H. Erbslöh. “Indena’s extensive range of mostly dry, highly purified plant extracts with proven efficacy even at very low concentrations, represents a completion to our portfolio and is a great offer to our customers in the conventional and “green” cosmetic sectors”, says Birgit Gertchen-Ohligschläger, SBU Manager Life Sciences at C.H. Erbslöh, commenting on the news.
The recent agreement is part of the Indena strategy to be more and more present in the cosmetic market worldwide. Indena and C.H.Erbslöh will work jointly to provide the German, Austrian and Benelux markets with the products and services both companies are known for.
About C.H.Erbslöh
C.H. Erbslöh, founded 1876, is an independent family-owned company operating in the 5th generation. Originally founded as a trading company for industrial chemicals, C.H. Erbslöh in its long history has developed into a specialized distributor serving different industries with a dedicated and highly qualified sales force. C.H. Erbslöh together with its European co-operation partners building the LEL-Alliance of technical distribution specialists reached a cumulated turnover of app. 280 million Euro in 2010. The strategic business unit Life Sciences takes pride in promoting and selling specialty products from renowned suppliers in Europe and overseas to its customers in the personal care, pharmaceutical and food supplement industries. The spectrum encompasses products ranging from technologically sophisticated and innovative active ingredients for cosmetics and personal care, through pharmaceutical excipients for use in human and veterinary applications to powerful ingredients for home care products.
About Indena
Indena is dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health food and cosmetics industries. Backed up by 90 years of botanical experience, the key to Indena’s success is its intense research activity. The company owns more than 150 primary patents and has published more than 700 scientific studies. Indena employs more than 800 staff, including 10% dedicated to full-time research activities carried out at Settala Research Center, near Milan. Indena also co-operates with the world’s most prestigious universities and private research institutions. Headquartered in Milan, Indena has 5 production sites and 4 international branches throughout the world and manages sales in more than 70 countries. The Company’s experts communicate and interact constantly with the major international regulatory authorities such as WHO, EMEA, and ESCOP, and cooperate on the update of all the main pharmacopoeias.